Last update 21 Nov 2024

SF2a-TT15 Synthetic Carbohydrate-based Conjugate Vaccine(Institut Pasteur)

Overview

Basic Info

Drug Type
Prophylactic vaccine, Conjugated vaccine
Synonyms-
Target-
Mechanism
Immunostimulants
Therapeutic Areas
Infectious DiseasesDigestive System DisordersOther Diseases
Active Indication
Dysentery, Bacillary
Inactive Indication-
Originator Organization
Institut PasteurInstitut Pasteur
Active Organization
Institut PasteurInstitut Pasteur
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with SF2a-TT15 Synthetic Carbohydrate-based Conjugate Vaccine(Institut Pasteur)
NCT04602975 / CompletedPhase 2
A Phase 2a Age Descending Study to Investigate the Safety and Immunogenicity of the SF2a-TT15 Synthetic Carbohydrate-based Conjugate Vaccine Against Shigella Flexneri 2a in Adults, Children, and Infant Target Population in Endemic Countries.
100 Clinical Results associated with SF2a-TT15 Synthetic Carbohydrate-based Conjugate Vaccine(Institut Pasteur)
Login to view more data
100 Translational Medicine associated with SF2a-TT15 Synthetic Carbohydrate-based Conjugate Vaccine(Institut Pasteur)
Login to view more data
100 Patents (Medical) associated with SF2a-TT15 Synthetic Carbohydrate-based Conjugate Vaccine(Institut Pasteur)
Login to view more data
100 Deals associated with SF2a-TT15 Synthetic Carbohydrate-based Conjugate Vaccine(Institut Pasteur)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Dysentery, BacillaryPhase 2
KE
Institut PasteurInstitut Pasteur
06 Oct 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free